Hepatitis C Virus NS5A Inhibits YAP1-HSC70 Interaction, Thereby Preventing YAP1 Degradation Via Chaperone-Mediated Autophagy. [PDF]
Septianastiti MA +6 more
europepmc +1 more source
Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection. [PDF]
Dybowska D, Pawłowska M, Kozielewicz D.
europepmc +1 more source
Screening and Characterization of TAT-Fused Nanobodies Targeting Bovine Viral Diarrhea Virus NS3/NS5A for Antiviral Application. [PDF]
Dong Q +6 more
europepmc +1 more source
Hepatitis C: current treatments, emerging therapies and tackling health inequities on the path to global elimination. [PDF]
Farooq HZ, Foster GR.
europepmc +1 more source
Hepatitis C Direct-Acting Antivirals in the Immunosuppressed Host: Mechanisms, Interactions, and Clinical Outcomes. [PDF]
AlKaabi H +4 more
europepmc +1 more source
Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR [PDF]
core +1 more source
Hepatitis C virus NS3/4A protease cleaves SPG20, a key regulator of lipid droplet turnover, to promote lipid droplet formation. [PDF]
Matsui C +4 more
europepmc +1 more source
Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems. [PDF]
Lin HM +12 more
europepmc +1 more source
The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistance. [PDF]
Chatterji U +8 more
europepmc +1 more source
Mechanistic and Kinetic Insights into the Acylation Reaction of Hepatitis C Virus NS3/NS4A Serine Protease with NS4B/5A Substrate. [PDF]
Martínez-González JÁ +4 more
europepmc +1 more source

